Healthspan Action Coalition
  • Home
  • About
    • About Us
    • Leadership
    • Policy
    • HSAC Internship
    • Why Join HSAC
  • The Coaltion
    • View the Coalition
    • HSAC Updates
    • Hawaii Healthspan Corridor
  • News & Video
    • Newsletters
    • Podcasts
    • News
    • Video
  • Events
    • Upcoming Events
    • Past Conference List
  • Resources
    • Boost Your Healthspan
    • Consumer Smart Guide
  • Contact
  • Donate Now
6 Longevity Economy Principles – The World Economic Forum Weighs In

6 Longevity Economy Principles – The World Economic Forum Weighs In

by admin | Jun 10, 2024 | news articles

By Avivah Wittenberg-Cox – Forbes – In an era where global life expectancy continues to rise, fertility falls and countries are shrinking demographically, the World Economic Forum’s new Longevity Economy Principles are not just timely—they’re...
AI Reasoning Flaws: The Limits of Popular Large Language Models

AI Reasoning Flaws: The Limits of Popular Large Language Models

by admin | Jun 8, 2024 | news articles

By Neuroscience News – Popular AI platforms like ChatGPT give inconsistent answers to reasoning tests and don’t improve with added context. The research highlights the need to understand AI ‘thinking’ before using them for decision-making. Despite advances, AI...
How Sinclair, Johnson, and Hyman reversed their biological age – and how you can too

How Sinclair, Johnson, and Hyman reversed their biological age – and how you can too

by admin | Jun 7, 2024 | news articles

By Jo Pinon – Longevity.Technology – Imagine waking up every morning with the vitality and energy of someone a decade younger. This isn’t a fantasy – it’s a reality for Dr David Sinclair, Bryan Johnson, and Dr Mark Hyman. These men claim to have reversed...
Turn Bio inks 0m epigenetic reprogramming deal with HanAll Biopharma

Turn Bio inks $300m epigenetic reprogramming deal with HanAll Biopharma

by admin | Jun 4, 2024 | news articles

by Danny Sullivan – Longevity.Technology – Longevity biotech Turn Biotechnologies today announced it has signed an exclusive global licensing agreement with Korean pharma giant HanAll Biopharma. The collaboration aims to develop multiple epigenetic...
How Gene Editing Therapies Could Go Beyond Rare Diseases

How Gene Editing Therapies Could Go Beyond Rare Diseases

by admin | Jun 3, 2024 | news articles

by Juergen Eckhardt  – Forbes – Earlier this year, a group of scientists in the Netherlands used the gene editing tool CRISPR to eliminate HIV from immune cells in the lab, an eye-catching approach that is forming the basis of potentially curative...
Why Turning 65 Isn’t What It Used to Be, According to an Expert

Why Turning 65 Isn’t What It Used to Be, According to an Expert

by admin | May 31, 2024 | news articles

By Sandra Block – Kiplinger – With more than 4 million people turning 65 in 2024, an expert in psychology and aging explains why so many of them are thriving like never before. A record number of Americans are turning 65 in 2024, and many of them are...
Page 70 of 138« First«153069707172...7590...»Last »

Recent Posts

  • Low Doses of Ozempic-Like Drug Can Counteract Aging in Older Mice, Study Finds
  • She cares for her aging parents full time. That requires taking care of herself, too
  • A Common Diabetes Drug Is Linked to ‘Exceptional Longevity’ in Women
  • Aging as a disease: The rise of longevity science
  • UW launches new research center to examine aging and age-related diseases

Subscribe to our newsletter to receive regular updates About Healthspan Action Coalition

Success!

Subscribe

We take your privacy seriously. No spam. See our Privacy Policy.

Healthspan Action Coalition Logo
  • Home
  • View Coalition
  • HSAC Updates
  • About Us
  • Leadership
  • Policy
  • Upcoming Events
  • Newsletters
  • Podcasts
  • News
  • Video
  • HSAC Internship
  • List of Past Conferences
  • Consumer Smart Guide
  • Donate Now
  • Contact Us
MAKE A DONATION
Download HSAC Overview
  • FollowFollow
  • FollowFollow
  • FollowFollow
Copyright © 2025 Healthspan Action Coalition, Inc. All rights reserved.